Inhibitory quotient as a prognostic factor of response to a salvage antiretroviral therapy containing ritonavir‐boosted saquinavir. The CIVSA Study *
暂无分享，去创建一个
M. Arnedo | T. Pumarola | J. Mallolas | X. Carné | A. Terrón | J. Gatell | P. Labarga | D. Dalmau | M. Sarasa | J. Blanco | A. Guelar | A. Vergara | A. Ocampo | Y. López-Púa | J. García | J. Juega | I. Garcia | M. Zárraga | E. Martínez | R. Escayola | E. Martinez